30 closest matches · ranked by relevance
Pain
Primary: Immediate Postoperative Pain Control — 6.6; 6.8 score on a scale
Chronic Non-malignant Pain
Primary: Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS") — 6.485; 6.645; 5.486; 6.210 score on a scale
Chronic Low Back Pain
Primary: Composite Pain Severity — 5.6; 5.6 score on a scale
Chronic Pain
Primary: Change From Baseline in Average Daily Opioid Dose in Morphine Milligram Equivalents (MME) at Month 12 — -11.6; -6.0 Morphine Milligram Equivalents (MME) — p=0.31
Surgical Procedure, Unspecified
Primary: PROMIS-CAT Pain — 59.32; 59.96; 56.94; 56.06 score on a scale
Chronic Pain · Pain, Intractable · Pain
Primary: Change in Visual Analog Scale (VAS) Score From Baseline to 2 Week Post Initial Fitting. — 35 participants with > 50% VAS improvement
Pain · Neoplasms
Primary: Feasibility of Mobile Application Assessed by Observing the Number of Daily Pain Assessments Recorded Among Patients — 2.37 pain assessments per day
Cancer · Pain
Primary: Average Pain Intensity Score — 1.192; 1.304 units on a scale
Postoperative Pain · Knee Replacement Arthroplasty
Primary: Post-Operative Pain — 2.9; 3.0 units on a scale — p=0.76
Reversible Pulpitis · Ibuprofen
Primary: Change in Pain Intensity From Baseline (Pre-Operative) to Immediately During the Procedure (Day 0), Measured by the Visual Analogue Scale (VAS) — 5.05; 0.64 score on a…
Postoperative Pain
Primary: Opioid Consumption in the 0-48 Hour Study Periods. — 10; 5; 10; 5 milligram morphine equivalents (MMEQ)
Depression · Opioid Use · Chronic Pain
Primary: Odds of Morphine Equivalent Daily Dose (MEDD) of Opioid Prescription >=50 mg — 0.209; 0.417; 0.185; 0.364 odds of prescription high dose — p=0.956
Cirrhosis, Liver
Primary: Number of Participants Attending ≥80% of Intervention Sessions — 16; 5 Participants
Pain, Chronic · Cancer
Primary: Improvement of Pain. — 3 score on a scale (0-10)
Opioid-use Disorder · Medication Assisted Treatment · Chronic Pain
Primary: Retention on Buprenorphine Treatment According to TimeLine Follow-Back - 3-months — 81.1; 75.4 days
Postoperative Pain
Primary: Length of Hospitalization — 4.54; 4.25 days
Cancer Pain
Primary: Feasibility - Pain Consultation — 29 Participants
Pain
Primary: Total Opioid Intake in Morphine Milligram Equivalents in the First 48 Hours After Cesarean Delivery (CD) — 42; 49.5 morphine milligram equivalents
Lumbar Spinal Fusions
Primary: Patient Controlled Analgesia (PCA) Hydromorphone Usage — 44; 39 mL
Pain, Postoperative · Urethral Stricture
Primary: Participant Pain Control: Numerical Rating Scale (NRS) — 1.2; .625 score on a scale
Chronic Pain
Primary: Daily Opioid Morphine Milligram Equivalents (MME) — 65.17; 67.51 MME/day — p=0.58
Chronic Pain
Primary: Decrease in Morphine Equivalent Dose (MED) — 85; 105 Participants
Chronic Pain
Primary: Opioid Tapering Success — 86; 61; 81; 0 Participants
Chronic Pain · Opiate Dependence · Lower Back Pain
Primary: Change in Quantitative Pain Testing Following Active TMS Compared to Baseline — 1.4; .3 Change from Baseline (degrees C) — p=.83
Chronic Pain
Primary: Chronic Pain Self-efficacy — 27.33; 33.66; 28.39; 35.57 score on a scale — p=<0.05
Sports Medicine Injuries
Primary: Pain Numerical Rating Scale (NRS) — 3.24; 3.04; 2.98; 3.02 score on a scale
Chronic Low-back Pain
Primary: Assessment of Opioid Use Via Subject Report — 47.5; 21.75 morphine milligram equivalent
Cerebral Palsy · Hip Dysplasia · Pain, Postoperative
Primary: Opioid Consumption — 0.41; 1.87 mEQ/kg
Nonspecific Pain Post Traumatic Injury
Primary: Opioid Use Per Day — 48; 34 MME per day
Back Pain · Osteoarthritis
Primary: Brief Pain Inventory Interference Scale — 3.7; 3.7; 3.4; 3.6 units on a scale